THAR Market Cap History Table | ||||||||
Also see: THAR Shares Outstanding History and THAR YTD Return |
THAR Market Cap History Table | ||||||||
Also see: THAR Shares Outstanding History and THAR YTD Return |
THAR Market Cap History Chart | |||||||||
-30.57% CAGR Mouse over chart for data details
|
THAR Stock Price Chart |
About Tharimmune Inc |
Tharimmune is engaged in the development of therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) for treating cancers. Co.'s product candidate is HSB-1216, an IMCD modulator, targeting solid tumors. Co.'s HSB-888, is a dual-loaded IMCD inducer coupled with its anthracycline analogue. Co.'s HSB-510 is a bifunctional inhibitory compound in Quatramer with single digit nanomolar IC50 against PI3K-delta and HDAC6. Co. owns HSB-114, which is a immunotherapeutic agent that delivers tumor necrosis factor-alpha gene into cancer cells. We show 3 historical shares outstanding datapoints in our THAR shares outstanding history coverage, used to compute THAR market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing THAR market cap history over the course of time is important for investors interested in comparing THAR's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of THAR versus a peer is one thing; comparing THAR market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like THAR can fluctuate over the course of history. With this page we aim to empower investors researching THAR by allowing them to research the THAR market cap history. |
THAR Current Stock Quote |
Free THAR Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
THAR Share Performance |
Market Cap Peers |
Tharimmune (THAR) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
THC Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.